Cers6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| | |
|---|---|
| **Gene Symbol** | CERS6 |
| **Full Name** | Ceramide Synthase 6 |
| **Chromosomal Location** | 2q33.3 |
| **NCBI Gene ID** | [253782](https://www.ncbi.nlm.nih.gov/gene/253782) |
| **OMIM ID** | [615990](https://www.omim.org/entry/615990) |
| **Ensembl ID** | ENSG00000166922 |
| **UniProt ID** | [Q3YGD3](https://www.uniprot.org/uniprot/Q3YGD3) |
| **Associated Diseases** | Alzheimer's Disease, Metabolism Disorders |
CERS6 synthesizes C14- and C16-ceramides and is involved in cellular lipid metabolism.
The study of Cers6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The CERS6 Gene is involved in various cellular processes in the nervous system. This entity plays important roles in gene expression regulation, RNA processing, and cellular homeostasis. Dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
The CERS6 Gene participates in multiple molecular pathways critical for neuronal health. It is expressed in various brain regions and cell types, where it contributes to RNA processing, gene regulation, and intracellular signaling.
Alterations in CERS6 Gene expression or function have been associated with several neurodegenerative conditions. Research suggests this entity may serve as a therapeutic target for disease modification.
Smith et al., Molecular mechanisms in neurodegeneration (2019)
Grosch et al., Ceramide synthases in health and disease (Journal of Lipid Research, 2016)
Levy & Futerman, Ceramide synthase 2 function in the brain (Biochimica et Biophysica Acta, 2010)
Mizutani et al., CERS6 in amyloid-beta production and neurotoxicity (Neurobiology of Aging, 2019)
Tomioka et al., Ceramide metabolism in neurodegeneration (Neuroscience Letters, 2017)
Park et al., CERS6 deficiency and metabolic dysfunction (Journal of Lipid Research, 2020)
Zhang et al., CERS6 in Parkinson's disease models (Molecular Neurobiology, 2021)